The Severity of COVID-19 in Diabetes Patients

被引：1

作者：

Danao, Kishor ^{[1
]}

Rokde, Vijayshri ^{[1
]}

Bali, Nikhil ^{[2
]}

Mahajan, Ujwala ^{[1
]}

机构：

[1] Dadasaheb Balpande Coll Pharm, Dept Pharmaceut Chem, Nagpur 440037, Maharashtra, India

[2] Rashtrasant Tukadoji Maharaj Nagpur Univ RTMNU, Dept Pharmaceut, Nagpur 440033, Maharashtra, India

来源：

CURRENT DIABETES REVIEWS | 2023年 / 19卷 / 05期

关键词：

Diabetes; COVID-19; ARBs; drug therapy; SARS-CoV-2; innate immunity; GLUCOSE-LEVELS; MORTALITY; MELLITUS; CORONAVIRUS; INFECTION; LOCKDOWN; INDIA; CARE;

D O I：

10.2174/1573399819666221006103113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aims Diabetic patients are significantly stimulated by COVID-19 infection. The dreadful risk of COVID-19 mortality may be affected. In order to preserve precious lives, it is essential to comprehend how diabetes and COVID-19 are related, as well as how to manage diabetes. We aimed to focus on the mechanism, impact, and drug treatment of diabetes in COVID-19 patients. Methods A comprehensive scrutiny of the published literature in diverse pharmaceutical and medical databases such as Google Scholar, PubMed, Science Direct, DOAJ etc., were successfully conducted and classified accordingly. Results We discussed the severity of COVID-19 in diabetes patients. A patient with diabetes has a higher risk of COVID-19 mortality by influencing the development and prognosis of the disease. The recommended drugs for diabetes treatment in COVID-19 may reduce COVID-19 mortality. Conclusion Metabolic syndrome diabetes is a risk factor enhancing the development and diagnosis of COVID-19. In order to treat diabetic patients who have COVID-19 infection, insulin is preferable over oral hypoglycemic medications.

引用

页数：5

共 42 条

[1] COVID-19 in people with diabetes: understanding the reasons for worse outcomes [J].

Apicella, Matteo ;

Campopiano, Maria Cristina ;

Mantuano, Michele ;

Mazoni, Laura ;

Coppelli, Alberto ;

Prato, Stefano Del .

LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (09) :782-792

[2] COVID-19 and diabetes mellitus: how one pandemic worsens the other [J].

Azar, William S. ;

Njeim, Rachel ;

Fares, Angie H. ;

Azar, Nadim S. ;

Azar, Sami T. ;

El Sayed, Mazen ;

Eid, Assaad A. .

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2020, 21 (04) :451-463

[3]

Bone N, 2020, AM J RESP CRIT CARE, V201

[4] Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic [J].

Brufsky, Adam .

JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) :770-775

[5] Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study [J].

Carey, Iain M. ;

Critchley, Julia A. ;

DeWilde, Stephen ;

Harris, Tess ;

Hosking, Fay J. ;

Cook, Derek G. .

DIABETES CARE, 2018, 41 (03) :513-521

[6] Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis [J].

Codo, Ana Campos ;

Davanzo, Gustavo Gastao ;

Monteiro, Lauar de Brito ;

de Souza, Gabriela Fabiano ;

Muraro, Stefanie Primon ;

Virgilio-da-Silva, Joao Victor ;

Prodonoff, Juliana Silveira ;

Carregari, Victor Corasolla ;

Oliveira de Biagi Junior, Carlos Alberto ;

Crunfli, Fernanda ;

Jimenez Restrepo, Jeffersson Leandro ;

Vendramini, Pedro Henrique ;

Reis-de-Oliveira, Guilherme ;

dos Santos, Karina Bispo ;

Toledo-Teixeira, Daniel A. ;

Parise, Pierina Lorencini ;

Martini, Matheus Cavalheiro ;

Marques, Rafael Elias ;

Carmo, Helison R. ;

Borin, Alexandre ;

Coimbra, Lais Durco ;

Boldrini, Vinicius O. ;

Brunetti, Natalia S. ;

Vieira, Andre S. ;

Mansour, Eli ;

Ulaf, Raisa G. ;

Bernardes, Ana F. ;

Nunes, Thyago A. ;

Ribeiro, Luciana C. ;

Palma, Andre C. ;

Agrela, Marcus, V ;

Moretti, Maria Luiza ;

Sposito, Andrei C. ;

Pereira, Fabricio Biscaro ;

Velloso, Licio Augusto ;

Ramirez Vinolo, Marco Aurelio ;

Damasio, Andre ;

Proenca-Modena, Jose Luiz ;

Carvalho, Robson Francisco ;

Mori, Marcelo A. ;

Martins-de-Souza, Daniel ;

Nakaya, Helder, I ;

Farias, Alessandro S. ;

Moraes-Vieira, Pedro M. .

CELL METABOLISM, 2020, 32 (03) :437-+

[7] Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes [J].

Cromer, Sara J. ;

Colling, Caitlin ;

Schatoff, Daria ;

Leary, Michael ;

Stamou, Maria, I ;

Selen, Daryl J. ;

Putman, Melissa S. ;

Wexler, Deborah J. .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (04)

[8] Diabetes, infection risk and COVID-19 [J].

Erener, Suheda .

MOLECULAR METABOLISM, 2020, 39

[9]

European Centre for Disease Prevention and Control and European Food Safety Authority, 2022, ABOUT US

[10] Metabolic Syndrome, Alzheimer's Disease, and Covid 19: A Possible Cor- relation [J].

Finelli, Carmine .

CURRENT ALZHEIMER RESEARCH, 2021, 18 (12) :915-924

← 1 2 3 4 5 →